Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Good Girl Rx vs WellMedr

By GLP-1 ScorecardUpdated

Good Girl Rx
Site position #455

Lower grade

WellMedr
Site position #221

Higher grade

Score comparison

WellMedr has the higher recorded score — 63.2/100 to 56.9/100.

WellMedr grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises low starting prices, but its 21-day and prepaid payment choices come with conflicting cancellation and refund terms; confirm the full bill and selected written agreement before committing.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueWellMedr +30
28
58
Dose & formulationGood Girl Rx +14
88
74
Clinical oversightWellMedr +16
55
71
Labs & monitoringWellMedr +6
52
58
FulfillmentGood Girl Rx +23
85
62
Contract termsWellMedr +3
41
44
Good Girl Rx · top barWellMedr · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricGood Girl RxWellMedr
WeighScore56.9/10063.2/100
GradeCC
Site position#455#221
Semaglutide$79/mo (microdose tier, 12-month plan, compounded)Advertised from $49/month; selected upfront total, plan term and renewal amount need confirmation
Tirzepatide$139/mo (microdose tier, 12-month plan, compounded)Advertised from $89/month; selected upfront total, plan term and renewal amount need confirmation
CoverageAll 50 statesGeneral service page lists all 50 states, DC, Puerto Rico and Guam; exact medication, clinical eligibility and pharmacy fulfillment remain conditional
Brand-name accessYesYes
Oral / sublingualYesYes
Good Girl Rx

Site position #455 · C

FDAWarning letter issued to Good Girl LLC dba GoodGirlRX in February 2026. See the FDA warning-letter database.

Strengths

  • LegitScript certified
  • Multiple formats — injectable, microdose, and ODT pills — for both semaglutide and tirzepatide
  • Dispensed by licensed 503A or 503B pharmacies
  • Limited brand-name options available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • Named legal entity with a Nashville address

What to consider

  • The advertised rates require twelve months paid up front; billed month to month the same products are $184 and $244, roughly 2.3 times as much
  • Every plan is prepaid — the discount exists only on the 3-, 6- and 12-month terms
  • The priced products are microdoses, not labeled therapeutic doses; the standard compounded semaglutide is $134/mo and also needs a year up front
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • FDA issued Good Girl LLC dba GoodGirlRX a warning letter in February 2026; the letter is public in FDA's warning-letter database
WellMedr

Site position #221 · C

Strengths

  • Publishes separate descriptions of 21-day billing and fully prepaid three-, six- and twelve-month plans
  • The refund policy provides detailed renewal and unused-prepayment rules, although important provisions conflict with the Terms
  • Current documents name possible pharmacy partners, including Logos, Emerald and Center City; the assigned facility still needs confirmation
  • The safety page distinguishes compounded preparations from FDA-approved products rather than treating shared ingredients as proof of equivalence

What to consider

  • Starting $49 and $89 advertisements do not establish the total due today, renewal amount or usable prescription supply; confirm whether membership and medication are separate charges
  • Four-week shipping is not the billing calendar; the separately described 21-day plan can generate more frequent charges
  • The refund policy accepts cancellation before a charge is submitted, while the Terms require two days’ notice and allow early renewal processing
  • Unused-prepayment allocation in the refund policy conflicts with discretionary partial refunds, medication-plan cancellation windows and a nonrefundable first membership month in the Terms; no legal priority is established
  • The ninety-day results-refund promise conflicts with policy language denying a results guarantee; clarify the selected written agreement
  • The current directory does not establish an available oral or microdose GLP-1 purchase; the homepage labels microdose Coming soon
  • Current documents do not identify the assigned clinical practice, clinician, dispenser or physical compounder; general service coverage does not guarantee every preparation

Featured provider

WellMedr

WellMedr scores 63.2/100 (C). Advertises low starting prices, but its 21-day and prepaid payment choices come with conflicting cancellation and refund terms; confirm the full bill and selected written agreement before committing.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard